Taizhou's CoWin to establish tech lab with Peking University

The Peking University Health Science Center in Beijing and CoWin Biotech – a listed group located in Taizhou city in East China's Jiangsu province – recently announced that they are joining forces.

The university center and the Taizhou company, which specializes in life science and health, announced on Dec 27 that they will establish a state-of-the-art technology laboratory. CoWin is mainly engaged in the R&D, manufacturing, and sales of molecular detection products. Additionally, it's in the business of molecular testing services.

The laboratory will serve as a joint research and development platform between the university and the company and will be based at the Institute for Advanced Clinical Medicine of Peking University.

Leveraging the world-class scientific research and transformation platform of the Peking University Health Science Center, the laboratory will aim to synergize CoWin's expertise in disease diagnosis and detection technology.

The joint effort will be dedicated to exploring cutting-edge clinical diagnostic technologies in genetic medicine, contributing to the advancement of national healthcare.

Situated in the Ganggang district of Taizhou, CoWin is a listed company on the Science and Technology Innovation Board of the Shanghai Stock Exchange (STAR Market).

With over 700 self-developed reagent products utilized in scientific research across various life science domains, CoWin is widely seen as being a prominent player in the sector.